BSEQualitek Labs LtdHighNeutral
Announced Wed, 20 May · 20:41 IST

Audited Standalone and Consolidated Financial Results as on 31.03.2026

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹400.00
prior close
₹450.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.4-6.6-2.9-4.2+2.0+2.5+4.3+5.0+4.5+2.0+3.0+0.0
Up moveDown movePending
AI summary

Qualitek Labs reported strong full-year results with consolidated revenue growing 77% to ₹12,451.81 Lakh (FY26) from ₹7,022.69 Lakh (FY25). Net profit surged approximately 90% to ₹1,460.15 Lakh from ₹768.36 Lakh year-on-year. On a standalone basis, revenue rose 47% to ₹6,762.45 Lakh and PAT grew 51% to ₹796.44 Lakh. The company has been actively expanding through acquisitions — it fully acquired Interstellar Testing Centre (now wholly-owned subsidiary), bought Quality & Testing Infosolution (100% stake), LabOps Global (74% stake), and a food testing laboratory in Mumbai for ₹882 Lakh. Borrowings nearly doubled to ₹9,297.55 Lakh (long-term ₹6,012.15 Lakh, short-term ₹3,285.40 Lakh). The statutory auditor issued an unmodified (clean) opinion on both standalone and consolidated results.

Likely market impact

The company delivered exceptional revenue and profit growth, boosted by acquisitions and organic expansion. However, the near-doubling of debt raises leverage risk. The clean audit provides confidence in financials, but investors should monitor the rising debt load and working capital requirements.